Table 1

Characteristics of FSWs living with HIV who remained on ART for at least 6 months in Kampala, Uganda

VariableCategoryIncluded in the analysis
(n=432), n (col %)
Sociodemographic characteristics
Age category
35–54151 (35)
25–34237 (55)
18–2444 (10)
Level of education
No education40 (9)
Primary251 (58)
Secondary and above141 (33)
Religion
Christian333 (77)
Muslim99 (23)
Marital status
Married19 (4)
Widowed47 (11)
Divorced/Separated288 (67)
Never married78 (18)
Source of income
Other in addition to sex work227 (53)
Sex work only205 (47)
Violence experience in the last 3 months
Yes148 (34)
No284 (66)
Alcohol use
Low risk188 (44)
Harmful/High risk182 (42)
Alcohol-dependent62 (14)
 Sexual behavioural characteristics
Condom use at last sexual intercourse
Yes259 (60)
No173 (40)
Lifetime sexual partners
<5077 (18)
≥50345 (80)
Missing10 (2)
 Participants’ clinical characteristics
Baseline CD4+ T-cell counts
≤350187 (43)
>350245 (57)
WHO stage
Stage I265 (61)
Stage II82 (19)
Stages III and IV37 (9)
Missing48 (11)
Place of ART initiation
Clinic-initiated374 (87)
Transfer-in58 (13)
ART regimen
First-line
AZT-3TC-EFV
AZT-3TC-NVP
TDF-3TC-EFV
TDF-3TC-NVP
5 (1)
17 (4)
378 (88)
22 (5)
Second-line
TDF-3TC-LPV/r
TDF-3TC-ATV/r
AZT-3TC-ATV/r
3 (1)
6 (1)
1 (0)
 Adherence status
Adherent359 (83)
Non-adherent73 (17)
 Duration on ART (years)Median (IQR)2.3 (1.8–3.2)
 Baseline CD4+ T-cell countMedian (IQR)395 (248–597)
Criteria for ART initiation
CD4 ≤350 cells/mm3 171 (40)
Test and treat261 (60)
  • ART, antiretroviral therapy; ATV/r, Atazanavir/Ritonavir; AZT, zidovudine; EFV, efavirenz; FSWs, female sex workers; LPV/r, Lopinavir/Ritonavir; NVP, nevirapine; 3TC, lamivudine; TDF, tenofovir.